A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
Government Engagement & Policy Manager

Margo Warren

Margo Warren is the Government Engagement & Policy Manager and is a member of the Strategy team at the Access to Medicine Foundation. Before taking on this role, she was a Researcher for the Access to Medicine Index.

Prior to joining the Foundation, Margo worked for the Ministry of Health and Long-Term Care in Ontario, Canada, in strategic health policy. In her position at the Ministry, Margo led the development of new initiatives pertaining to improving access to medicine, health system strengthening and capacity building.

Margo has held various health research and policy positions focused on partnerships for development, improving access to care, and addressing the social determinants of health both in Canada and globally. Margo holds both a Bachelor’s degree and a Master's degree in international development with a focus on health policy. Her Master’s thesis explored the complexities of producing affordable generic medications in low- and middle-income countries. To support this work, she completed an independent field study, analysing the domestic production of antiretrovirals in Uganda as a viable option to help increase access to medicine.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |